Table 1.
ADHD | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Instrument | Reference | Sample1 | M/F or total N 2 | Age in years3 | Res4 | Interval (days)5 | ADHD | ODD | CD | SAD | GAD | MDD | Ave7 |
CAPA | Eggera | clin | 307 | 2–5 | P | 3–28 | .74 | .57 | .60 | .60 | .39 | .72 | .60 |
Angoldb | clin | 77 | 10–16 | P | 1–11 | n/a | n/a | .55 | n/a | .79 | .90 | .75 | |
K‐SADS‐PL | Chambersc | clin | 31/21 | 6–17 | Co | <3 | n/a | n/a | .63 | n/a | .24 | .54 | .47 |
DISC | Hod | clin | 78 | 9–18 | P | 22 | .81 | .55 | n/a | n/a | .51 | .82 | .67 |
Hod | clin | 78 | 9–18 | Y | 22 | .25 | .41 | n/a | n/a | .37 | .58 | .40 | |
Bravoe | clin | 97/49 | 4–17 | P | 12 | .506 | .456 | .476 | .646 | .446 | .486 | .49 | |
Bravoe | clin | 83 | 11–17 | Y | 12 | n/a | n/a | .62 | .18 | n/a | .15 | .32 | |
Shafferf | clin | 84 | 9–17 | P | 6.6 | .79 | .54 | .43 | .58 | .65 | .66 | .61 | |
Shafferf | clin | 82 | 9–17 | Y | 6.6 | .42 | .51 | .65 | .46 | n/a | .92 | .59 | |
Schwab‐Stoneg | clin | 39 | 11–17 | P | 7–21 | .55 | .88 | .87 | n/a | n/a | .72 | .76 | |
Schwab‐Stoneg | clin | 41 | 11–17 | Y | 7–21 | n/a | .16 | .55 | .72 | n/a | .77 | .55 | |
Flisherh | comb | 71/34 | 15.0 (2.2) | P | 14 | .56 | .66 | n/a | n/a | .457 | .66 | .58 | |
Jenseni | clin | 73/24 | 9–17 | P | 13 | .69 | .67 | .70 | n/a | .58 | .69 | .67 | |
Jenseni | clin | 73/24 | 9–17 | Y | 13 | .59 | .46 | .86 | n/a | .39 | .38 | .54 | |
Jenseni | comm | 129/149 | 9–17 | P | 21 | .57 | .65 | .66 | n/a | .40 | .00 | .46 | |
Jenseni | comm | 129/149 | 9–17 | Y | 21 | .43 | .23 | .60 | n/a | .30 | .29 | .37 | |
Bretonj | comm | 260 | 6–14 | P | 14 | .60 | .56 | n/a | .44 | .57 | .32 | .50 | |
Bretonj | comm | 145 | 12–14 | Y | 14 | n/a | n/a | .49 | .59 | .53 | .55 | .54 | |
Riberak | comm | 124 | 9–17 | Co | <14 | .53 | .56 | .82 | .46 | –.03 | .29 | .44 | |
Schwab‐Stonel | comm | 130/117 | 9–18 | P | 1–15 | .606 | .686 | .566 | .456 | .606 | .556 | .57 | |
Schwab‐Stonel | comm | 130/117 | 9–18 | Y | 1–15 | .106 | .186 | .646 | .276 | .286 | .376 | .31 | |
DICA | Boylem | comm | 210 | 6–16 | P | 7–21 | .59 | .51 | .21 | .32 | .57 | .70 | .48 |
Boylen | comm | 137 | 12–16 | Y | 7–21 | .24 | .28 | .92 | n/a | .54 | .45 | .49 | |
Ezpeletao | clinic | 110 | 7–177 | P | 11 | .53 | n/a | .77 | .56 | .59 | .10 | .51 | |
Ezpeletao | clinic | 110 | 7–177 | Y | 11 | .79 | n/a | .27 | .39 | .47 | .66 | .52 | |
Ezpeletap | comm | 244 | 3–7 | P | 4–40 | .83 | .65 | n/a | .76 | .50 | .67 | .68 | |
MINI‐KID | Sheehanq | comb | 83 | 6–17 | Co | 1–5 | .87 | .71 | .85 | .70 | .64 | .75 | .75 |
Ave Parent/Co8 | .65 | .61 | .62 | .52 | .46 | .56 | .57 | ||||||
Ave Youth9 | .34 | .32 | .67 | .44 | .40 | .50 | .45 |
Note: CAPA, Child and Adolescent Psychiatric Assessment; K‐SADS‐PL, Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime; DISC, Diagnostic Interview Schedule for Children; DICA, Diagnostic Interview for Children and Adolescents; MINI‐KID, Mini International Neuropsychiatric Interview for Children and Adolescents; ADHD, attention deficit hyperactivity disorder; ODD, oppositional defiant disorder; CD, conduct disorder; SAD, separation anxiety disorder; GAD, generalized anxiety disorder; MDD, major depressive disorder; n/a, not assessed.
Sample: clin = clinic, comb = clinic and community, comm = community.
M/F = males/females or total N = total sample size.
Age in years = minimum/maximum or mean, standard deviation.
Res = Respondent, P = parent; Y = youth; Co = combined parent and youth.
Interval (days) = minimum‐maximum or mean.
Age groups 7–11 and 12–17 years combined and average kappa reported.
Ave = mean kappa value across disorders for parent/combined and for youth.
Ave Parent/Co = mean kappa value for disorders assessed by parents averaged across studies.
Ave Youth = mean kappa value for disorders assessed by youth averaged across studies.
Egger et al. (2006);
Angold and Costello (1995);
Chambers et al. (1985);
Ho et al. (2005);
Bravo et al. (2001);
Shaffer et al. (2000);
Schwab‐Stone et al. (1993);
Flisher, Sorsdahl, and Lund (2012)
Jensen et al. (1995)
Breton, Bergeron, Valla, Berthiaume, and St‐Georges (1998);
Ribera et al. (1996);
Schwab‐Stone et al. (1996);
Boyle et al. (1997);
Boyle et al. (1993b);
Ezpeleta, de la Osa, Domènech, Navarro, and Losilla (1997);
Ezpeleta, de la Osa, Granero, Domènech, and Reich (2011);
Sheehan et al. (2010).